Skip to main content

Advertisement

Log in

Robotic D2 surgery for gastric cancer

  • Letter
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Anderson C, Hellan M, Kernstine K, Ellenhorn J, Lai L, Trisal V, Pigazzi A (2007) Robotic surgery for gastrointestinal malignancies. Int J Med Robot 3(4):297–300

    PubMed  CAS  Google Scholar 

  2. Ramirez PT, Soliman PT, Schmeler KM, dos Reis R, Frumovitz M (2008) Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol 110(3 Suppl 2):S21–S24

    Article  PubMed  Google Scholar 

  3. Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22(5):1405–1406

    Article  PubMed  Google Scholar 

  4. McLeod R (2008) Long-term results of laparoscopic-assisted colectomy are comparable to results after open colectomy. Ann Surg 248(1):8–9

    Article  PubMed  Google Scholar 

  5. Patriti A, Ceccarelli G, Bellochi R, Bartoli A, Spaziani A, Di Zitti L, Casciola L (2008) Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma. Surg Endosc, Sep 24 [Epub ahead of print]

  6. Sasako M, Sano T, Yamamoto S, For Japan Clinical Oncology Group et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359(5):453–462

    Article  PubMed  CAS  Google Scholar 

  7. Liakakos T, Roukos DH (2008) More controversy than ever—challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol 15(4):956–960

    Article  PubMed  Google Scholar 

  8. Kappas AM, Roukos DH (2002) Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol 9(9):828–830

    Article  PubMed  Google Scholar 

  9. Roukos DH (2004) Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 11:127–129

    Article  PubMed  Google Scholar 

  10. Briasoulis E, Fatouros M, Roukos DH (2007) Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14:2691–2695

    PubMed  Google Scholar 

  11. Roukos DH (2002) Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9:220–221

    Article  PubMed  Google Scholar 

  12. Briasoulis E, Liakakos T, Dova L et al (2006) Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Rev Anticancer Ther 6:931–939

    Article  PubMed  Google Scholar 

  13. Punglia RS, Morrow M, Winer EP et al (2007) Local therapy and survival in breast cancer. N Engl J Med 356:2399–2405

    Article  PubMed  CAS  Google Scholar 

  14. Roukos DH, Kappas AM, Agnantis NJ (2003) Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol 10:718–721

    Article  PubMed  Google Scholar 

  15. Fatouros M, Roukos DH, Arampatzis I, Sotiriadis A, Paraskevaidis E, Kappas AM (2005) Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther 5(4):737–745

    Article  PubMed  Google Scholar 

  16. Roukos DH (2008) Linking contralateral breast cancer with genetics. Radiother Oncol 86:139–141

    Article  PubMed  Google Scholar 

  17. Chung DC, Yoon SS, Lauwers GY, Patel D (2007) Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer. N Engl J Med 357(3):283–291

    Article  PubMed  CAS  Google Scholar 

  18. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247(4):714–715

    Article  PubMed  Google Scholar 

  19. Roukos DH, Murray S, Briasoulis E (2007) Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol Ther 6(3):308–312

    Article  PubMed  CAS  Google Scholar 

  20. Roukos DH, Briasoulis E (2007) Individualized preventive and therapeutic management of hereditary breast ovarian cancer. Nat Clin Pract Oncol 4(10):578–590

    Article  PubMed  CAS  Google Scholar 

  21. Roukos DH (2007) Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(15):1555–1556 author reply 1556

    Article  PubMed  CAS  Google Scholar 

  22. Fatouros M, Baltoyiannis G, Roukos DH (2008) The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15(1):21–33

    Article  PubMed  Google Scholar 

  23. Roukos DH, Agnanti NJ, Paraskevaidis E, Kappas AM (2002) Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann Surg Oncol 9(10):941–943

    PubMed  Google Scholar 

  24. Agnantis NJ, Paraskevaidis E, Roukos D (2004) Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance. Ann Surg Oncol 11(12):1030–1034

    Article  PubMed  Google Scholar 

  25. Roukos DH (2008) Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn 8(5):587–597

    Article  PubMed  Google Scholar 

  26. Roukos DH, Lykoudis E, Liakakos T (2008) Genomics and challenges toward personalized breast cancer local control. J Clin Oncol 26(26):4360–4361

    Article  PubMed  Google Scholar 

  27. Roukos DH (2008) HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 358:197 author reply 198

    Article  PubMed  CAS  Google Scholar 

  28. Roukos DH (2008) Breast-cancer stromal cells with TP53 mutations. N Engl J Med 358(15):1636 author reply 1636

    PubMed  CAS  Google Scholar 

  29. Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360(13):1362–1363

    Article  PubMed  CAS  Google Scholar 

  30. Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16(4):795–798

    Article  PubMed  Google Scholar 

  31. Roukos DH (2009) Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol 16(3):772–773

    Article  PubMed  Google Scholar 

  32. Roukos DH (2009) Genome-wide association studies: how predictable is a person’s cancer risk? Expert Rev Anticancer Ther 9(4):389–392

    Article  PubMed  Google Scholar 

  33. Roukos DH (2009) Mea culpa with cancer-targeted therapy: new thinking and new agents design for novel, casual networks-based, personalized biomedicine. Expert Rev Mol Diagn 9(3):217–221

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Ziogas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demetetriades, H., Marakis, G.N., Ziogas, D. et al. Robotic D2 surgery for gastric cancer. Surg Endosc 23, 1919–1921 (2009). https://doi.org/10.1007/s00464-009-0496-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-009-0496-1

Keywords

Navigation